Showing results (201-210 of 261) with videos related to
Sort By:
Pageof 27
Royal Society Open Science|May 7, 2021
Spatial cognitive ability is associated with transitory movement speed but not straightness during the early stages of explorationChristine E Beardsworth, Mark A Whiteside, Lucy A Capstick, et al.Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.The British Journal of Dermatology|June 5, 2015
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trialK Papp, D Thaçi, K Reich, et al.Dermatology and Therapy|February 15, 2022
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17April W Armstrong, Andrew Blauvelt, Ulrich Mrowietz, et al.Journal of the American Academy of Dermatology|October 8, 2011
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trialsKenneth B Gordon, Kim A Papp, Richard G Langley, et al.JAMA Dermatology|April 9, 2020
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical TrialAndrew Blauvelt, Craig L Leonardi, Melinda Gooderham, et al.The Journal of Dermatological Treatment|May 2, 2024
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up studyNina Magnolo, Michael C Cameron, Mona Shahriari, et al.The New England Journal of Medicine|April 23, 2021
Bimekizumab versus Adalimumab in Plaque PsoriasisRichard B Warren, Andrew Blauvelt, Jerry Bagel, et al.Journal of the American Academy of Dermatology|April 15, 2020
The use of noninvasive imaging techniques in the diagnosis of melanoma: a prospective diagnostic accuracy studyA Nikolas MacLellan, Emma L Price, Pamela Publicover-Brouwer, et al.The Journal of Dermatological Treatment|August 5, 2021
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE studyAndrew Blauvelt, April W Armstrong, Richard G Langley, et al.Pageof 27